Keywords: connetics, ms, vaccine, clears, phase, i/ii, trial

Connetics MS Vaccine Clears Phase I/II Trial

Article | 21 January 1998

Print This

Connetics Corp of Palo Alto in California, USA, has completed a PhaseI/II study of its candidate T-cell receptor vaccine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in